Fintel reports that on December 17, 2025, Canaccord Genuity maintained coverage of InMode (NasdaqGS:INMD) with a Hold recommendation. Analyst Price Forecast Suggests 18.34% Upside As of December 6, ...
InMode Ltd. remains a global leader in minimally invasive aesthetic medical devices, trading at a deep discount with a net cash position covering 58% of market cap. Despite a sharp 85% drawdown since ...
If you want to know who really controls InMode Ltd. (NASDAQ:INMD), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are institutions ...
The latest update is out from InMode ( (INMD)). On November 5, 2025, InMode Ltd. announced its financial results for the third quarter of 2025, reporting revenues of $93.2 million, a decrease from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback